We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
-3.93%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$58.4M
AUM Growth
-$35.8M
Cap. Flow
-$33.5M
Cap. Flow %
-57.3%
Top 10 Hldgs %
41.11%
Holding
109
New
27
Increased
13
Reduced
25
Closed
40

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$2.5M
2
NXPI icon
NXP Semiconductors
NXPI
+$2.09M
3
WDC icon
Western Digital
WDC
+$1.49M
4
CI icon
Cigna
CI
+$1.16M
5
NVS icon
Novartis
NVS
+$962K

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$3.44M
2
HUM icon
Humana
HUM
+$2.73M
3
BABA icon
Alibaba
BABA
+$2.34M
4
DIS icon
Walt Disney
DIS
+$1.74M
5
PYPL icon
PayPal
PYPL
+$1.72M

Sector Composition

Rank Sector Weight
1 Healthcare 49.52%
2 Technology 26.41%
3 Financials 2.04%
4 Communication Services 1.9%
5 Consumer Discretionary 1.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VYGR icon
51
Voyager Therapeutics
VYGR
$201M
$196K 0.34%
11,378
-66
-0.6% -$1.39K
DERM
52
DELISTED
Dermira, Inc.
DERM
$192K 0.33%
29,998
-431
-1% -$3.6K
DLPH
53
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
$190K 0.33%
+14,179
New +$225K
LAB icon
54
Standard BioTools
LAB
$314M
$164K 0.28%
35,352
+21,131
+149% +$166K
CHRS icon
55
Coherus Oncology
CHRS
$196M
$158K 0.27%
7,806
-4,801
-38% -$95.9K
FATE icon
56
Fate Therapeutics
FATE
$326M
$138K 0.24%
8,899
-3,429
-28% -$65.7K
TW icon
57
Tradeweb Markets
TW
$21.6B
$79K 0.14%
2,132
– –
TECX
58
Tectonic Therapeutic
TECX
$606M
$66K 0.11%
+389
New +$88.1K
ACOR
59
DELISTED
Acorda Therapeutics
ACOR
$57K 0.1%
+166
New +$90.2K
AXNX
60
DELISTED
Axonics, Inc. Common Stock
AXNX
$52K 0.09%
+1,937
New +$67.5K
AMK
61
DELISTED
AssetMark Financial Holdings, Inc.
AMK
$25K 0.04%
+961
New +$25.8K
LVGO
62
DELISTED
Livongo Health, Inc. Common Stock
LVGO
$25K 0.04%
+1,444
New +$43.7K
EIDX
63
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$22K 0.04%
+607
New +$23.7K
EQ icon
64
Equillium
EQ
$133M
$20K 0.03%
5,333
-1,599
-23% -$6.87K
ELGX
65
DELISTED
Endologix Inc
ELGX
$11K 0.02%
+2,882
New +$16.8K
ALGN icon
66
Align Technology
ALGN
$12.3B
– –
-2,325
Closed -$636K
AMGN icon
67
CALL
Amgen
AMGN
$222B
– –
-3,000
Closed -$553K
AMGN icon
68
PUT
Amgen
AMGN
$222B
– –
-13,600
Closed -$2.51M
AVTR icon
69
Avantor
AVTR
$9.19B
– –
-11,964
Closed -$228K
CRWD icon
70
CrowdStrike
CRWD
$218B
– –
-6,920
Closed -$118K
DBX icon
71
Dropbox
DBX
$8.12B
– –
-18,959
Closed -$475K
DIS icon
72
Walt Disney
DIS
$181B
– –
-12,429
Closed -$1.74M
ELV icon
73
Elevance Health
ELV
$85.5B
– –
-3,473
Closed -$980K
ESPR
74
DELISTED
Esperion Therapeutics
ESPR
– –
-15,722
Closed -$731K
EXAS
75
DELISTED
Exact Sciences
EXAS
– –
-5,014
Closed -$592K
1 2
3
4 5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q3 2019 Portfolio in Review

As of Q3 2019, Partner Investment Management held 109 positions worth $58.4M, down 38% from $94.2M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Partner Investment Management withdrew a net $33.5M in Q3 2019, closing 40 positions and reducing 25 holdings. Its most notable exit was Humana, an estimated $2.73M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 44% a quarter earlier, followed by Technology and Financials.

Against the trend, Partner Investment Management opened a new position in Alexion Pharmaceuticals worth $2.17M.

  • Partner Investment Management's largest Q3 2019 buy was Alexion Pharmaceuticals: 22,136 shares worth $2.17M.
  • Partner Investment Management added most to Twilio in Q3 2019, an estimated $926K increase.
  • Partner Investment Management's biggest Q3 2019 reduction was Allergan plc, cutting an estimated $3.44M.
  • Partner Investment Management fully exited Humana in Q3 2019, selling an estimated $2.73M.
  • Partner Investment Management's ten largest holdings make up 41% of its $58.4M portfolio in Q3 2019.
  • Partner Investment Management opened 27 new positions and closed 40 in Q3 2019.
  • Partner Investment Management's portfolio value fell 38% quarter-over-quarter to $58.4M.

Based on Partner Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.